The Effect of Metformin in Overweight Patients with Type 1 Diabetes and Poor Metabolic Control
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Metformin as adjunct to intensive insulin therapy may improve glucose metabolism and thereby prevent the development of cardiovascular risk factors in patients with type 1 diabetes. Double‐blinded intervention with 2000 mg metformin or placebo daily in 24 type 1 diabetic patients as adjunct to intensive insulin therapy. Primary endpoint was HbA1c, while secondary endpoints were body weight, frequency of hypoglycaemia, blood pressure, lipids, insulin dosage and self‐monitored blood glucose profiles were measured. After 24 weeks, no difference in HbA1c was seen between the metformin and placebo groups (−0.5 ± 0.3 vs. −0.2 ± 0.2%, P = 0.26. Δ mean ± S.E.M). Mean diurnal blood glucose profiles showed no statistical significant difference between the groups. The total daily insulin dose (IU) was significantly reduced in the metformin group compared to placebo after 24 weeks (−5.9 ± 2.2 vs. 2.9 ± 1.7, P = 0.004. Δ mean ± S.E.M). An increase in the frequency of hypoglycaemia was seen in the metformin group (0.7 ± 0.9 vs. 0.3 ± 0.5 events patient−1 week−1, P = 0.005), and a reduction in body weight was found using metformin compared to placebo (−3.0 ± 1.0 vs. 0.8 ± 1.1, P = 0.02. Δ mean ± S.E.M). Lipids and blood pressure did not differ significantly after intervention. Metformin, as adjunct to intensive insulin therapy, was associated with a reduction in the total daily insulin dose and a significant weight loss in patients with type 1 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Can clinical factors estimate insulin resistance in type 1 diabetes?
Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S., & Orchard, T. J. (2000) · Diabetes · doi:10.2337/diabetes.49.4.626 · Cited by 640
The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes
Paterson, A. D., Rutledge, B. N., Cleary, P. A., Lachin, J. M., Crow, R. S., & for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2007) · Diabetes Care · doi:10.2337/dc06-1441 · Cited by 81
Cited by
The use of metformin in type 1 diabetes: a systematic review of efficacy
Vella, S., Buetow, L., Royle, P., Livingstone, S., Colhoun, H. M., & Petrie, J. R. (2010) · Diabetologia · doi:10.1007/s00125-009-1636-9 · Cited by 201
“Randomised metformin trials in adults with type 1 diabetes (n=10) [16, 17, 20, 21, 23, 25, 26, 63–65] No informed consent (n=1) [64] Intervention trials meeting inclusion criteria (n=9) [16, 17, 20, 21, 23, 25, 26, 63, 65] Fig.”
BackgroundMethodResultInfluentialMeng, H., Zhang, A., Liang, Y., Hao, J., Zhang, X., & Lu, J. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2983 · Cited by 56
Liu, Y., Chen, C., Chen, Z., Peng, Y., Lin, X., & Xu, L. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3334 · Cited by 36
Management of severe insulin resistance in patients with type 1 diabetes
Schechter, R., & Reutrakul, S. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0641-2 · Cited by 15
MUSIL, F., ŠMAHELOVÁ, A., BLÁHA, V., HYŠPLER, R., TICHÁ, A., LESNÁ, J., ZADÁK, Z., & SOBOTKA, L. (2013) · Physiological Research · doi:10.33549/physiolres.932381 · Cited by 12
Metadata
- Authors
- Jacobsen, I. B., Henriksen, J. E., & Beck‐Nielsen, H.
- Venue
- Basic & Clinical Pharmacology & Toxicology
- Publisher
- Wiley
- Published
- 2009-08-11
- Volume
- 105
- Issue
- 3
- Pages
- 145-149
- ISSN
- 1742-7835 (ISSN-L)
- 1742-7843
- OpenAlex
- W2040132182
- Cited by
- 69
- References
- 4
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Metformin in Overweight Patients with Type 1 Diabetes and Poor Metabolic Control. https://app.cochat.ai/papers/10.1111/j.1742-7843.2009.00380.x
- The paper
- Jacobsen, I. B., Henriksen, J. E., & Beck‐Nielsen, H. (2009). The Effect of Metformin in Overweight Patients with Type 1 Diabetes and Poor Metabolic Control. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/j.1742-7843.2009.00380.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.